FDA Inspection 1209403 — James Devin Mattingly
The FDA completed an inspection of James Devin Mattingly on June 29, 2023 in Lebanon, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 29, 2023
- Fiscal Year
- 2023
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Lebanon, KY (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 22694 | FDCA 402(a)(2)(C)(ii) | Introduction/delivery into IS - illegal drug residue |
| 4185 | FDCA 402(a)(4) | Record keeping |